All terms in MESH
| Label | Id | Description |
|---|---|---|
| samarangenin B | C471026 | |
| beta-lactamase bla(KLUA), Klyvera ascorbata | C471027 | |
| AT 130 | C471028 | |
| 7-(3-(aminomethyl)-4-(methoxyimino)-3-methyltetrahydro-1H-1-pyrrolyl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro(1,8)naphthyridine-3-carboxylic acid | C471029 | |
| 3-methyl pyrrole-2,4-dicarboxylic acid 2-propyl ester 4-(1,2,2-trimethyl-propyl) ester | C485660 | |
| 7-(5'-(3'-phenylisoxazolino)methyl)-8-hydroxyquinoline | C485661 | |
| 3-cyclopentyloxy-4-methoxybenzaldehyde | C485662 | |
| 3-cyclopentyloxy-4-methoxybenzoic acid | C485663 | |
| Kcnh4 protein, rat | C485664 | |
| Anxa10 protein, mouse | C485665 | |
| 1'-(3-phenylpropyl)-3,4-dihydrospiro((2)benzopyran-1,4'-piperidin)-3-ol | C446057 | |
| Fgd2 protein, mouse | C485666 | |
| 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzonitrile | C446058 | |
| LBX2 protein, human | C485667 | |
| Dizocilpine Maleate | D016291 | [A potent noncompetitive antagonist of the NMDA receptor (RECEPTORS, N-METHYL-D-ASPARTATE) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which NMDA receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.] |
| 4-((1-(2-(2,4-difluorophenyl)ethyl)-4-piperidinyl)sulfonyl)benzamide | C446059 | |
| GRIN1 protein, human | C485668 | |
| Conscious Sedation | D016292 | [A drug-induced depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by light tactile stimulation. No interventions are required to maintain a patent airway. (From: American Society of Anesthesiologists Practice Guidelines)] |
| Anesthesia and Analgesia | D000760 | [Medical methods of either relieving pain caused by a particular condition or removing the sensation of pain during a surgery or other medical procedure.] |
| TLL2 protein, human | C485669 |